{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T18:09:15Z","timestamp":1774289355252,"version":"3.50.1"},"reference-count":10,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100005240","name":"Administration for Children and Families","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005240","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","jaacap.org","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Child & Adolescent Psychiatry"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/j.jaac.2020.03.009","type":"journal-article","created":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T15:28:26Z","timestamp":1591025306000},"page":"213-215","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Editorial: Why JAACAP Published an \u201cInconclusive\u201d Trial: Optimize, Optimize, Optimize Psychostimulant Treatment"],"prefix":"10.1016","volume":"60","author":[{"given":"Samuele","family":"Cortese","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4475-8596","authenticated-orcid":false,"given":"Douglas K.","family":"Novins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaac.2020.03.009_bib1","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.jaac.2019.12.009","article-title":"Stepped treatment for attention-deficit\/hyperactivity disorder and aggressive behavior: a randomized, controlled trial of adjunctive risperidone, divalproex sodium, or placebo after stimulant medication optimization","volume":"60","author":"Blader","year":"2021","journal-title":"J\u00a0Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.jaac.2020.03.009_bib2","doi-asserted-by":"crossref","first-page":"e1577","DOI":"10.1542\/peds.2010-1361","article-title":"Treatment of maladaptive aggression in youth: CERT guidelines II. Treatments and ongoing management","volume":"129","author":"Scotto Rosato","year":"2012","journal-title":"Pediatrics"},{"key":"10.1016\/j.jaac.2020.03.009_bib3","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/S2215-0366(18)30269-4","article-title":"Comparative efficacy and tolerability of medications for attention-deficit hyperactivity disorder in children, adolescents, and adults: a systematic review and network meta-analysis","volume":"5","author":"Cortese","year":"2018","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.jaac.2020.03.009_bib5","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1097\/CHI.0b013e3181bac557","article-title":"The MTA at 8","volume":"48","author":"Banaschewski","year":"2009","journal-title":"J\u00a0Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.jaac.2020.03.009_bib6","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.jaac.2019.05.015","article-title":"A\u00a0double-blind randomized placebo-controlled trial of citalopram adjunctive to stimulant medication in youth with chronic severe irritability","volume":"59","author":"Towbin","year":"2020","journal-title":"J\u00a0Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.jaac.2020.03.009_bib7","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/j.jaac.2019.07.002","article-title":"Debate: are stimulant medications for attention-deficit\/hyperactivity disorder effective in the long term? (For)","volume":"58","author":"Coghill","year":"2019","journal-title":"J\u00a0Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.jaac.2020.03.009_bib8","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1007\/s00787-013-0393-y","article-title":"What influences clinicians' decisions about ADHD medication? Initial data from the Influences on Prescribing for ADHD Questionnaire (IPAQ)","volume":"22","author":"Kovshoff","year":"2013","journal-title":"Eur Child Adolesc Psychiatry"},{"key":"10.1016\/j.jaac.2020.03.009_bib9","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2016-0223","article-title":"Discontinuation and nonpublication of randomized clinical trials conducted in children","volume":"138","author":"Pica","year":"2016","journal-title":"Pediatrics"},{"key":"10.1016\/j.jaac.2020.03.009_bib10","doi-asserted-by":"crossref","first-page":"f2865","DOI":"10.1136\/bmj.f2865","article-title":"Restoring invisible and abandoned trials: a call for people to publish the findings","volume":"346","author":"Doshi","year":"2013","journal-title":"BMJ"},{"key":"10.1016\/j.jaac.2020.03.009_bib11","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.jaac.2019.05.002","article-title":"Editorial: better treatments and the importance of publishing negative clinical trials","volume":"58","author":"Novins","year":"2019","journal-title":"J\u00a0Am Acad Child Adolesc Psychiatry"}],"updated-by":[{"DOI":"10.1016\/j.jaac.2021.03.014","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000}}],"container-title":["Journal of the American Academy of Child & Adolescent Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S089085672030335X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S089085672030335X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,3,17]],"date-time":"2022-03-17T05:31:03Z","timestamp":1647495063000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S089085672030335X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":10,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["S089085672030335X"],"URL":"https:\/\/doi.org\/10.1016\/j.jaac.2020.03.009","relation":{"erratum":[{"id-type":"doi","id":"10.1016\/j.jaac.2021.03.014","asserted-by":"object"}]},"ISSN":["0890-8567"],"issn-type":[{"value":"0890-8567","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Editorial: Why JAACAP Published an \u201cInconclusive\u201d Trial: Optimize, Optimize, Optimize Psychostimulant Treatment","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Child & Adolescent Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaac.2020.03.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.jaac.2019.12.009","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a92020 American Academy of Child and Adolescent Psychiatry","name":"copyright","label":"Copyright"}]}}